In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing

PCSK9 基因组编辑 前蛋白转化酶 清脆的 生物 突变 可欣 胞嘧啶 基因 遗传学 突变 计算生物学 生物化学 低密度脂蛋白受体 胆固醇 脂蛋白
作者
Alexandra C. Chadwick,Xiao Wang,Kiran Musunuru
出处
期刊:Arteriosclerosis, Thrombosis, and Vascular Biology [Lippincott Williams & Wilkins]
卷期号:37 (9): 1741-1747 被引量:223
标识
DOI:10.1161/atvbaha.117.309881
摘要

Objective— High-efficiency genome editing to disrupt therapeutic target genes, such as PCSK9 (proprotein convertase subtilisin/kexin type 9), has been demonstrated in preclinical animal models, but there are safety concerns because of the unpredictable nature of cellular repair of double-strand breaks, as well as off-target mutagenesis. Moreover, precise knock-in of specific nucleotide changes—whether to introduce or to correct gene mutations—has proven to be inefficient in nonproliferating cells in vivo. Base editors comprising CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats [CRISPR]-CRISPR-associated 9) fused to a cytosine deaminase domain can effect the alteration of cytosine bases to thymine bases in genomic DNA in a sequence-specific fashion, without the need for double-strand DNA breaks. The efficacy of base editing has not been established in vivo. The goal of this study was to assess whether in vivo base editing could be used to modify the mouse Pcsk9 gene in a sequence-specific fashion in the liver in adult mice. Approach and Results— We screened base editors for activity in cultured cells, including human-induced pluripotent stem cells. We then delivered a base editor into the livers of adult mice to assess whether it could introduce site-specific nonsense mutations into the Pcsk9 gene. In adult mice, this resulted in substantially reduced plasma PCSK9 protein levels (>50%), as well as reduced plasma cholesterol levels (≈30%). There was no evidence of off-target mutagenesis, either cytosine-to-thymine edits or indels. Conclusions— These results demonstrate the ability to precisely introduce therapeutically relevant nucleotide variants into the genome in somatic tissues in adult mammals, as well as highlighting a potentially safer alternative to therapeutic genome editing.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
mkbk的应助被嘻嘻哈哈采纳,获得260
2秒前
3秒前
Liam发布了新的文献求助10
3秒前
搜集达人的应助被xxcub采纳,获得10
4秒前
常富育发布了新的文献求助10
4秒前
5秒前
星辰大海的应助被无误采纳,获得10
6秒前
6秒前
医学小牛马完成签到,获得积分10
8秒前
ri_290完成签到,获得积分10
8秒前
bibabu完成签到,获得积分20
9秒前
酷酷静白完成签到 ,获得积分10
10秒前
yuhaipeng0123发布了新的文献求助10
10秒前
xxcub完成签到,获得积分10
10秒前
华仔的应助被urology dog采纳,获得10
10秒前
11秒前
11秒前
Alrtoca发布了新的文献求助10
11秒前
11秒前
Liam完成签到,获得积分10
12秒前
坚强台灯完成签到 ,获得积分10
12秒前
王多鱼关注了科研通微信公众号
14秒前
菊花普洱发布了新的文献求助10
14秒前
小月亮完成签到,获得积分10
14秒前
14秒前
No4发布了新的文献求助10
15秒前
科研通AI65的应助被bibabu采纳,获得10
16秒前
潇洒谷槐完成签到,获得积分10
18秒前
19秒前
mkbk的应助被嘻嘻哈哈采纳,获得250
20秒前
beibei发布了新的文献求助10
20秒前
临州完成签到,获得积分20
22秒前
小苏发布了新的文献求助10
22秒前
abab完成签到,获得积分10
23秒前
23秒前
Alrtoca完成签到,获得积分10
24秒前
田様的应助被bzd采纳,获得10
24秒前
24秒前
tszjw168发布了新的文献求助10
25秒前
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192903
求助须知:如何正确求助?哪些是违规求助? 9579346
关于积分的说明 21864636
捐赠科研通 7792529
什么是DOI,文献DOI怎么找? 3437107
关于科研通互助平台的介绍 2560653
邀请新用户注册赠送积分活动 2483937